Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33493663/
The continued introduction of biomarkers and innovative testing methods makes already complex diagnosis in patients with stage IV non-small-cell lung cancer (NSCLC) even more complex. This study primarily analyzed variations...
Therapeutic strategies in RET gene rearranged non-small cell lung cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33771190/
The recent approvals by the Food and Drug Administration several tumor-agnostic drugs have resulted in a paradigm shift in cancer treatment from an organ/histology-specific strategy to biomarker-guided approaches. RET gene...
Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33121202/
GLOBOCAN 2018 identified lung cancer as the leading oncological pathology in terms of incidence and mortality rates. Angiogenesis is a key adaptive mechanism of numerous malignancies that promotes metastatic spread...
NCCN Updates Clinical Practice Guideline for Small Cell Lung Cancer
On March 23, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for small cell lung cancer. The version 3.2021 update features modifications for...
Efficacy and safety of anti-angiogenic drugs combined with erlotinib in the treatment of advanced non-small cell lung cancer: a meta-analysis of randomized clinical trials
Source : https://apm.amegroups.com/article/view/61988/html
Lung cancer remains the leading cause of death among cancer patients worldwide, and approximately 85% of lung cancers are non-small cell lung cancer (NSCLC) ( 1). A series of clinical...